✦ LIBER ✦

Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17

✍ Scribed by Alain Li-Wan-Po; Thierry Girard; Peter Farndon; Candy Cooley; James Lithgow

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical importance of the CYP2C19*17 va

✍ Michael J. Dolton; Andrew J. McLachlan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 425 KB

Assessment of CYP2C19 genetic polymorphi

✍ K.-A. Kim; W.-K. Song; K.-R. Kim; J.-Y. Park 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB

CYP2C19 pharmacogenetics in advanced can

✍ Helsby, N A; Lo, W-Y; Sharples, K; Riley, G; Murray, M; Spells, K; Dzhelai, M; S 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 130 KB

Moclobemide, a substrate of CYP2C19 and

✍ Gram, Lars F.; Guentert, Theodor W.; Grange, Susan; Vistisen, Kirsten; BrÃ¸sen, 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 817 KB

Pharmacogenetics of acenocoumarol: CYP2C

✍ R. B. Saraeva; I. D. Paskaleva; E. Doncheva; C. B. Eap; V.S. Ganev 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

The combined impact of CYP2C19 and CYP2B

✍ Nuala A. Helsby; Chung-Yee Hui; Michael A. Goldthorpe; Janet K. Coller; May Chin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 919 KB